Testing effectiveness (Phase 2)Study completedNCT01997905What this trial is testingStroke Feasibility StudyWho this might be right forAtrial FibrillationAFib AtriCure, Inc. 13
Not applicableStudy completedNCT04590287What this trial is testingICF in Secondary Prevention of Cardiovascular DiseaseWho this might be right forCardiovascular DiseasesSecondary PreventionRisk Factor, Cardiovascular Poznan University of Medical Sciences 120
Not applicableStudy completedNCT04382963What this trial is testingStroke Prevention in the Wisconsin Native American PopulationWho this might be right forStrokeAtherosclerosis University of Wisconsin, Madison 120
Not applicableStudy completedNCT01968122What this trial is testingRegistry Study of Stenting for Symptomatic Intracranial Artery Stenosis in ChinaWho this might be right forIschemic Stroke Zhongrong Miao 300
Not applicableEnded earlyNCT03783754What this trial is testingTriple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-studyWho this might be right forStrokeCerebral Small Vessel DiseasesIntracerebral Hemorrhage+2 more The George Institute 4
Not applicableUnknownNCT02967484What this trial is testingAcupuncture Lowering Blood Pressure for Secondary Prevention of StrokeWho this might be right forCerebral Infarction First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 480
Large-scale testing (Phase 3)Looking for participantsNCT05293080What this trial is testingEarly Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKEWho this might be right forAcute Ischemic StrokeAtrial Fibrillation Universitätsklinikum Hamburg-Eppendorf 1,746
Large-scale testing (Phase 3)Study completedNCT02675790What this trial is testingModerate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan AfricaWho this might be right forSickle Cell DiseaseSickle Cell AnemiaStroke Vanderbilt University Medical Center 120
Post-approval studies (Phase 4)Study completedNCT03090113What this trial is testingShuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With EmbolismWho this might be right forEmbolic Stroke Beijing Tiantan Hospital 2,416
Large-scale testing (Phase 3)Not Yet RecruitingNCT07746882What this trial is testingStudy on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation TherapyWho this might be right forStrokeAcute Ischemic Stroke Second Affiliated Hospital, Zhejiang University, School of Medicine 680
Not applicableUnknownNCT04547387What this trial is testingTCAR Cerebral Protection And MicroNET-Covered Stent To Reduce StrokesWho this might be right forCarotid Artery Diseases John Paul II Hospital, Krakow 50
Post-approval studies (Phase 4)Study completedNCT01109836What this trial is testingAustrian Polyintervention Study to Prevent Cognitive Decline After Ischemic StrokeWho this might be right forIschemic StrokeCognitive DeclineDementia Danube University Krems 202
Large-scale testing (Phase 3)Study completedNCT00403767What this trial is testingAn Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationWho this might be right forAtrial FibrillationStrokeEmbolism Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269
Not applicableStudy completedNCT02559232What this trial is testingAn Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care CentersWho this might be right forStrokePrevention and ControlAtrial Fibrillation Bayer 247
Not applicableUnknownNCT03838341What this trial is testingStand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation.Who this might be right forStroke PreventionAtrial FibrillationSafety Issues Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 100
Post-approval studies (Phase 4)Study completedNCT02168829What this trial is testingOptimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation TrialWho this might be right forAtrial FibrillationStroke Ottawa Heart Institute Research Corporation 1,284
Not applicableEnded earlyNCT04733339What this trial is testingInvestigating Adherence to Cereneo Tele-service Support After Clinical Disharge in Stroke PatientsWho this might be right forStroke, Ischemic Cereneo AG 2
Not applicableStudy completedNCT00861354What this trial is testingHome Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure MonitorWho this might be right forAtrial Fibrillation Microlife 150
Not applicableStudy completedNCT06359756What this trial is testingIschemic Postconditioning in Carotid SurgeryWho this might be right forIschemic PostconditioningCarotid SurgeryStroke+1 more Institute for Cardiovascular Diseases Dedinje 40
Large-scale testing (Phase 3)Looking for participantsNCT07430956What this trial is testingStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is UnsuitableWho this might be right forAtrial Fibrillation (AF) Regeneron Pharmaceuticals 2,628